Fed. Circ. Told Atelvia Skepticism Shows Patent Isn't Obvious
Warner Chilcott urged a Federal Circuit panel Monday to reverse a finding stemming from a bench trial that two patent claims for its osteoporosis drug Atelvia were obvious, saying the scientific...To view the full article, register now.
Already a subscriber? Click here to view full article